Results 301 to 310 of about 2,468,898 (371)

Sunitinib in metastatic renal cell carcinoma: clinical outcomes across risk groups in a Turkish Oncology Group Kidney Cancer Consortium

open access: yes
Cancer Communications, EarlyView.
Hatice Bolek   +17 more
wiley   +1 more source

VEGF receptors mediate hypoxic remodeling of adult ovine carotid arteries.

open access: yesJ Appl Physiol (1985), 2014
Adeoye OO   +4 more
europepmc   +1 more source

Exploring recent advances in signaling pathways and hallmarks of uveal melanoma: a comprehensive review. [PDF]

open access: yesExplor Target Antitumor Ther
Banimohammad M   +9 more
europepmc   +1 more source

The biology of VEGF and its receptors

Nature Medicine, 2003
Vascular endothelial growth factor (VEGF) is a key regulator of physiological angiogenesis during embryogenesis, skeletal growth and reproductive functions. VEGF has also been implicated in pathological angiogenesis associated with tumors, intraocular neovascular disorders and other conditions.
N. Ferrara, H. Gerber, J. Lecouter
semanticscholar   +4 more sources

Soluble VEGF receptors

Angiogenesis, 2004
The three human VEGF receptors 1-3 mediate biological signals important for new blood vessel formation and lymphangiogenesis. Soluble VEGF receptors contain all the information necessary for high affinity ligand binding and have been used as experimental tools and regulators in several angiogenic in vitro and in vivo models.
Carsten Hornig, H. Weich
semanticscholar   +4 more sources

VEGFs, receptors and angiogenesis

Seminars in Cancer Biology, 1999
Angiogenesis, the formation of new blood vessels from pre--existing ones, is central for both normal development and homeostasis as well as in certain pathological conditions. The vascular endothelial growth factors (VEGFs) and their receptors are prime regulators of both physiological and pathological angiogenesis. The different VEGFs have overlapping
Kari Alitalo, Tanja Veikkola
openaire   +3 more sources

Abstract LB-346: Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages

Tumor Biology, 2016
OBJECTIVE: Here we aimed to overcome resistance to anti-VEGF therapy in glioblastoma (GBM), the most common and aggressive adult primary brain tumor.
T. Peterson   +22 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy